Human serum albumin inhibits Aβ fibrillization through a "monomer-competitor" mechanism

Biophysical Journal

Volumn 97, Issue 9, 2009, Pages 2585-2594

  Milojevic, Julijana ^a   Raditsis, Annie ^a   Melacini, Giuseppe ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[12-28]; HUMAN SERUM ALBUMIN; MONOMER; TRYPTOPHAN; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; FIBER; OLIGOMERIZATION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 72249108028     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.08.028     Document Type: Article

References (32)

1. Cummings, J. L. 2004. Alzheimer's disease. N. Engl. J. Med. 351:56-67.
2. Haass, C., and D. J. Selkoe. 1993. Cellular processing of β- amyloid precursor protein and the genesis of amyloid β -peptide. Cell. 73:1039-1042. (Pubitemid 2023512)
3. Walsh, D. M., I. Klyubin, J. V. Fadeeva, W. K. Cullen, R. Anwyl, et al. 2002. Naturally secreted oligomers of the Alzheimer amyloid β-protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:535-539.
4. Dahlgren, K. N., A. M. Manelli, W. K. Stine, L. K. Baker, Jr., G. A. Krafft, et al. 2002. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277:32046-32053.
5. Zlokovic, B. V. 2004. Clearing amyloid through the blood-brain barrier. J. Neurochem. 89:807-811.
6. Biere, A. L., B. Ostaszewski, E. R. Stimson, B. T. Hyman, J. E. Maggio, et al. 1996. Amyloid β -peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 271:32916-32922.
7. Bohrmann, B., L. Tjernberg, P. Kuner, S. Poli, B. Levet-Trafit, et al. 1999. Endogenous proteins controlling amyloid β -peptide polymerization. J. Biol. Chem. 274:15990-15995.
8. Hoyer, W., C. Gronwall, A. Jonsson, S. Stahl, and T. Hard. 2008. Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation. Proc. Natl. Acad. Sci. USA. 105:5099-5104.
9. Narayanan, S., B. Bosl, S. Walter, and B. Reif. 2003. Importance of low-oligomeric-weight species for prion propagation in the yeast prion system Sup35/Hsp104. Proc. Natl. Acad. Sci. USA. 100:9286-9291.
10. Evans, K. C., E. P. Berger, C. G. Cho, K. H. Weisgraber, and P. T. Lansbury. 1995. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 92:763-767.
11. Milojevic, J., V. Esposito, R. Das, and G. Melacini. 2007. Understanding the molecular basis for the inhibition of the Alzheimer's Aβ-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy. J. Am. Chem. Soc. 129:4282-4290.
12. Kuo, Y. M., T. A. Kokjohn, W. Kalback, D. Luehrs, D. R. Galasko, et al. 2000. Amyloid-β peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem. Biophys. Res. Commun. 268:750-756.
13. Rozga, M., M. Koniecki, M. Jabonowskaa, M. Dadlez, and W. Bala. 2000. The binding constant for amyloid Aβ 40 peptide interaction with human serum albumin. Biochem. Biophys. Res. Commun. 364:714-718.
14. Reyes Barcelo, A. A., F. J. Gonzalez-Velasquez, and M. A. Moss. 2009. Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells. J. Biol. Eng. 3:1-8.
15. Jarvet, J., P. Damberg, K. Bodell, L. E. G. Erksson, and A. Graslund. 2000. Reversible random coil to β-sheet transition and the early stage of aggregation of the A β (12-28) fragment from the Alzheimer peptide. J. Am. Chem. Soc. 122:4261-4268.
16. Huang, H., J. Milojevic, and G. Melacini. 2008. Analysis and optimization of saturation transfer difference NMR experiments designed to map early self-association events in amyloidogenic peptides. J. Phys. Chem. B. 112:5795-5802.
17. 1H off-resonance relaxation. J. Am. Chem. Soc. 127:9358-9359.
18. Mayer, M., and B. Mayer. 2001. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J. Am. Chem. Soc. 123:6108-6117.
19. Piotta, M., V. Saudek, and V. Sklenar. 1992. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR. 2:661-666.
20. Thumser, A. E. A., A. G. Buckland, and D. C. Wilton. 1998. Monoacyl-glycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site. J. Lipid Res. 39:1033-1038.
21. Bojko, B., A. Sulkowska, M. Maciazek, J. Rownicka, F. Njau, et al. 2008. Changes of serum albumin affinity for aspirin induced by fatty acid. Int. J. Biol. Macromol. 42:314-323.
22. Dockal, M., C. D. Carter, and F. Ruker. 2000. Conformational transitions of the three recombinant domains of human serum albumin depending on pH. J. Biol. Chem. 275:3042-3050.
23. Benseny-Cases, N., M. Cocera, and J. Cladera. 2007. Conversion of non-fibrillar β-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation. Biochem. Biophys. Res. Commun. 361:916-921.
24. Stockman, B. J., and C. Dalvit. 2002. NMR screening techniques in drug discovery and drug design. Prog. Nucl. Magn. Reson. Spectrosc. 41:187-231.
25. Yang, J., and D. S. Hage. 1996. Role of binding capacity versus binding strength in the separation of chiral compounds on protein-based high-performance liquid chromatography columns interactions of D- and L-tryptophan with human serum albumin. J. Chromatogr. A. 725:273-285.
26. Bocedi, A., S. Notaril, P. Narciso, B. Alessandro, M. Fasano, et al. 2004. Binding of anti-HIV drugs to human serum albumin. IUBMB Life. 56:609-614. (Pubitemid 40385357)
27. Miles, I. C., and H. G. Schenk. 1970. Fluorescence of acetylsalicylic acid in solution and its measurement in presence of salicylic acid. Anal. Chem. 42:656-659.
28. Hou, L., H. Shao, Y. Zhang, H. Li, N. K. Menon, et al. 2004. Solution NMR studies of the Aβ (1-40) and Aβ (1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J. Am. Chem. Soc. 126:1992-2005.
29. Walsh, P., J. Yau, K. Simonetti, and S. Sharpe. 2009. Morphology and secondary structure of stable b-oligomers formed by amyloid peptide PrP(106-126). Biochemistry. 48:5779-5781.
30. Priyankar, S., F. Sadaf, A. Basir, and H. K. Rizwan. 2009. Interactions of thioflavin T with serum albumins: spectroscopic analyses. Spectrochim. Acta Part A. 74:94-99.
31. Lomakin, A., D. S. Chung, G. B. Benedek, D. A. Kirschner, and D. B. Teplow. 1996. On the nucleation and growth of amyloid β-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. USA. 93:1125-1129.
32. Nanga, R. P. R., J. R. Brender, J. Xu, K. Hartman, V. Subramanian, et al. 2009. Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. J. Am. Chem. Soc. 131:8252-8261.